Norges Bank’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $31M | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $41.6M | Sell |
|
|||||
|
2024
Q3 | $65.1M | Sell |
|
|||||
|
2024
Q2 | $61.9M | Sell |
|
|||||
|
2024
Q1 | $81.2M | Buy |
|
|||||
|
2023
Q4 | $73.1M | Sell |
|
|||||
|
2023
Q3 | $81.5M | Hold |
|
|||||
|
2023
Q2 | $86.2M | Buy |
|
|||||
|
2023
Q1 | $108M | Buy |
|
|||||
|
2022
Q4 | $91.4M | Buy |
|
|||||
|
2022
Q3 | $84.2M | Buy |
|
|||||
|
2022
Q2 | $97.9M | Sell |
|
|||||
|
2022
Q1 | $118M | Sell |
|
|||||
|
2021
Q4 | $161M | Buy |
|
|||||
|
2021
Q3 | $154M | Sell |
|
|||||
|
2021
Q2 | $134M | Sell |
|
|||||
|
2021
Q1 | $120M | Buy |
|
|||||
|
2020
Q4 | $120M | Sell |
|
|||||
|
2020
Q3 | $114M | Buy |
|
|||||
|
2020
Q2 | $97.3M | Buy |
|
|||||
|
2020
Q1 | $73.2M | Sell |
|
|||||
|
2019
Q4 | $78.2M | Buy |
|
|||||
|
2019
Q3 | $69.7M | Buy |
|
|||||
|
2019
Q2 | $65M | Hold |
|
|||||
|
2019
Q1 | $63.6M | Buy |
|
|||||
|
2018
Q4 | $46.3M | Buy |
|
|||||
|
2018
Q3 | $60.1M | Buy |
|
|||||
|
2018
Q2 | $51.4M | Sell |
|
|||||
|
2018
Q1 | $44.9M | Buy |
|
|||||
|
2017
Q4 | $41.6M | Hold |
|
|||||
|
2017
Q3 | $38.7M | Sell |
|
|||||
|
2017
Q2 | $41.4M | Buy |
|
|||||
|
2017
Q1 | $32M | Buy |
|
|||||
|
2016
Q4 | $26.2M | Sell |
|
|||||
|
2016
Q3 | $26.4M | Hold |
|
|||||
|
2016
Q2 | $24.1M | Hold |
|
|||||
|
2016
Q1 | $23.1M | Hold |
|
|||||
|
2015
Q4 | $23.4M | Buy |
|
|||||
|
2015
Q3 | $22.6M | Hold |
|
|||||
|
2015
Q2 | $25.3M | Hold |
|
|||||
|
2015
Q1 | $22.7M | Buy |
|
|||||
|
2014
Q4 | $18.6M | Hold |
|
|||||
|
2014
Q3 | $17.5M | Sell |
|
|||||
|
2014
Q2 | $37M | Buy |
|
|||||
|
2014
Q1 | $19.8M | Hold |
|
|||||
|
2013
Q4 | $19.1M | Hold |
|
|||||
|
2013
Q3 | $18.2M | Buy |
|
|||||
|
2013
Q2 | $11.6M | Buy |
|